Ortho-McNeil Pharmaceutical, Inc.
Patent Owner
Stats
- 379 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 17, 2013 most recent publication
Details
- 379 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 7,768 Total Citation Count
- Apr 08, 1988 Earliest Filing
- 121 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8497373 Phosphonic acid compounds as inhibitors of serine proteasesMay 15, 12Jul 30, 13[A61K, C07F, C07D]
8278268 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulatorsOct 24, 07Oct 02, 12[A61K]
8198440 Phosphonic acid compounds as inhibitors of serine proteasesOct 24, 08Jun 12, 12[A61K, C07F, C07D]
8183213 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulatorsOct 24, 07May 22, 12[A61K]
8133726 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseOct 06, 10Mar 13, 12[C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8609888 Phosphonic acid compounds as inhibitors of serine proteasesExpiredJul 17, 12Dec 17, 13[A61K, C07F]
8501791 1,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsExpiredJul 13, 10Aug 06, 13[A61K, C07D]
7754730 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsExpiredNov 16, 06Jul 13, 10[A61K]
7557244 Substituted biphenyl carboxylic acids and derivatives thereofExpiredApr 20, 07Jul 07, 09[A01N, C07D, C07C]
7468373 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsExpiredJun 29, 05Dec 23, 08[A61K]
7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptorsExpiredJan 18, 06Jul 15, 08[A01N]
7375123 1,2,4-thiadiazole derivatives as melanocortin receptor modulatorsExpiredFeb 01, 06May 20, 08[A61K]
7345052 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsExpiredJun 29, 05Mar 18, 08[A61K]
7329654 Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulatorsExpiredDec 02, 02Feb 12, 08[A61P]
7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsExpiredNov 04, 02Jan 15, 08[A61K]
7226940 Substituted heterocycles for the treatment of diabetes and other diseasesExpiredAug 24, 05Jun 05, 07[A61K]
2007/0098,734 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseAbandonedOct 13, 06May 03, 07[A61K, C12N]
7196108 Bicyclic heterocycles for the treatment of diabetes and other diseasesExpiredMar 06, 03Mar 27, 07[A61K]
2007/0054,888 NOVEL SUBSTITUTED DIAMINE DERIVATIVES USEFUL AS MOTILIN AGONISTSAbandonedNov 02, 06Mar 08, 07[A61K, C07D]
7172900 Isolated CD8.sup.+T lymphocytes specifically cytotoxic for a disease causing target cellWithdrawnMay 13, 02Feb 06, 07[C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.